APPLICATION
Application Note
For IHC-P: Use at a dilution of 1:30. It is recommended to perform heat mediated antigen retrieval before starting with IHC protocol. Optimal dilutions/concentrations should be determined by the researcher.
Calculated MW
Positive Control
Human Brain Tissue
PROPERTIES
Form
Liquid
Buffer
PBS, 0.2% BSA
Preservative
0.1% Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE.
Concentration
0.3 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Human
Immunogen
PGP 9.5 from human brain
Purification
Protein A affinity purified
Conjugation
Unconjugated
RRID
AB_377956
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
ubiquitin C-terminal hydrolase L1 , HEL-117 , HEL-S-53 , NDGOA , PARK5 , PGP 9.5 , PGP9.5 , PGP95 , SPG79 , Uch-L1
Cellular Localization
Cytoplasm , Endoplasmic reticulum membrane
Background
The protein encoded by this gene belongs to the peptidase C12 family. This enzyme is a thiol protease that hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. This gene is specifically expressed in the neurons and in cells of the diffuse neuroendocrine system. Mutations in this gene may be associated with Parkinson disease.[provided by RefSeq, Sep 2009]
Database
Research Area
REFERENCE
There are currently no references for PGP9.5 antibody [13C4] (GTX72095). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for PGP9.5 antibody [13C4] (GTX72095). Be the first to share your experience with this product.